Financial News · Live Terminal

Page 198 of 227

Cytokinetics Insider Sold Shares Worth $270,795, According to a Recent SEC Filing

Fady Ibraham Malik, Executive Vice President, Research & Development, on May 05, 2026, sold 3,500 shares in Cytokinetics (CYTK) for $270,795. Following the Form 4 filing with the SEC, Malik has control over a total of 153,902 common shares of the company, with 153,902 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1061983/000106198326000051/xslF345X05/form4.xml

$CYTK

Insider Trading141d ago

F5 Insider Sold Shares Worth $1,006,637, According to a Recent SEC Filing

Kunal Anand, Chief Technology Officer, on May 01, 2026, sold 3,123 shares in F5 (FFIV) for $1,006,637. Following the Form 4 filing with the SEC, Anand has control over a total of 12,194 common shares of the company, with 12,194 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1048695/000201685726000006/xslF345X05/wk-form4_1778017126.xml

$FFIV

Insider Trading141d ago

Heritage Insurance Holdings Insider Sold Shares Worth $266,753, According to a Recent SEC Filing

Sharon Binnun, Chief Accounting Officer, on May 01, 2026, sold 9,200 shares in Heritage Insurance Holdings (HRTG) for $266,753. Following the Form 4 filing with the SEC, Binnun has control over a total of 123,988 common shares of the company, with 123,988 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1598665/000163940726000010/xslF345X05/wk-form4_1778016830.xml

$HRTG

Insider Trading141d ago

Everspin Technologies Insider Sold Shares Worth $557,227, According to a Recent SEC Filing

Sanjeev Aggarwal, Director, President and CEO, on May 04, 2026, sold 28,459 shares in Everspin Technologies (MRAM) for $557,227. Following the Form 4 filing with the SEC, Aggarwal has control over a total of 819,422 common shares of the company, with 819,422 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1438423/000162828026030750/xslF345X05/wk-form4_1778016363.xml

$MRAM

Insider Trading141d ago

JPMorgan Chase Insider Sold Shares Worth $1,522,037, According to a Recent SEC Filing

Jennifer Piepszak, Chief Operating Officer, on May 05, 2026, sold 4,919 shares in JPMorgan Chase (JPM) for $1,522,037. Following the Form 4 filing with the SEC, Piepszak has control over a total of 85,082 common shares of the company, with 85,082 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/19617/000122520826004965/xslF345X05/doc4.xml

$JPM

Insider Trading141d ago

JPMorgan Chase Insider Sold Shares Worth $1,259,356, According to a Recent SEC Filing

Ashley Bacon, Chief Risk Officer, on May 05, 2026, sold 4,070 shares in JPMorgan Chase (JPM) for $1,259,356. Following the Form 4 filing with the SEC, Bacon has control over a total of 248,785 common shares of the company, with 248,785 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/19617/000122520826004966/xslF345X05/doc4.xml

$JPM

Insider Trading141d ago

JPMorgan Chase Insider Sold Shares Worth $935,032, According to a Recent SEC Filing

Jeremy Barnum, Chief Financial Officer, on May 05, 2026, sold 3,022 shares in JPMorgan Chase (JPM) for $935,032. Following the Form 4 filing with the SEC, Barnum has control over a total of 32,438 common shares of the company, with 32,438 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/19617/000122520826004967/xslF345X05/doc4.xml

$JPM

Insider Trading141d ago

Fortinet Insider Sold Shares Worth $476,035, According to a Recent SEC Filing

Ken Xie, Director, President & CEO, on May 01, 2026, sold 5,355 shares in Fortinet (FTNT) for $476,035. Following the Form 4 filing with the SEC, Xie has control over a total of 57,826,778 common shares of the company, with 52,978,004 shares held directly and 4,848,774 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1262039/000147558726000010/xslF345X05/form4-05052026_090524.xml

$FTNT

Insider Trading141d ago

Vertex Pharmaceuticals Insider Sold Shares Worth $469,222, According to a Recent SEC Filing

Joy Liu, Executive Vice President and Chief Legal Officer, on May 01, 2026, sold 1,104 shares in Vertex Pharmaceuticals (VRTX) for $469,222. Following the Form 4 filing with the SEC, Liu has control over a total of 20,729 common shares of the company, with 20,729 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/875320/000087532026000183/xslF345X05/wk-form4_1778015480.xml

$VRTX

Insider Trading141d ago

Cadence Design Systems Insider Sold Shares Worth $3,559,500, According to a Recent SEC Filing

Paul Scannell, Senior Vice President, on May 01, 2026, sold 10,500 shares in Cadence Design Systems (CDNS) for $3,559,500. Following the Form 4 filing with the SEC, Scannell has control over a total of 33,946 common shares of the company, with 33,946 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/813672/000081367226000048/xslF345X05/wk-form4_1778015627.xml

$CDNS

Insider Trading141d ago

Cadence Design Systems Insider Sold Shares Worth $337,490, According to a Recent SEC Filing

Paul Cunningham, Senior Vice President, on May 01, 2026, sold 1,000 shares in Cadence Design Systems (CDNS) for $337,490. Following the Form 4 filing with the SEC, Cunningham has control over a total of 127,586 common shares of the company, with 127,586 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/813672/000081367226000049/xslF345X05/wk-form4_1778015633.xml

$CDNS

Insider Trading141d ago

Old Dominion Freight Line Insider Sold Shares Worth $4,233,826, According to a Recent SEC Filing

Greg C Gantt, Director, on May 04, 2026, sold 22,107 shares in Old Dominion Freight Line (ODFL) for $4,233,826. Following the Form 4 filing with the SEC, Gantt has control over a total of 88,821 common shares of the company, with 88,551 shares held directly and 270 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/878927/000197724926000029/xslF345X05/form4.xml

$ODFL

Insider Trading141d ago

Circle Internet Group Insider Sold Shares Worth $1,120,898, According to a Recent SEC Filing

Jeremy Fox-Geen, Chief Financial Officer, on May 01, 2026, sold 11,438 shares in Circle Internet Group (CRCL) for $1,120,898. Following the Form 4 filing with the SEC, Fox-Geen has control over a total of 355,611 Class A common shares of the company, with 355,611 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1876042/000181800826000001/xslF345X05/wk-form4_1778015050.xml

$CRCL

Insider Trading141d ago

Clorox Insider Bought Shares Worth $429,124, According to a Recent SEC Filing

Pierre R Breber, Director, on May 05, 2026, executed a purchase for 5,000 shares in Clorox (CLX) for $429,124. Following the Form 4 filing with the SEC, Breber has control over a total of 18,000 common shares of the company, with 18,000 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/21076/000122520826004962/xslF345X05/doc4.xml

$CLX

Insider Trading141d ago

Kiniksa Pharmaceuticals International Insider Sold Shares Worth $3,137,823, According to a Recent SEC Filing

John F. Paolini, Chief Medical Officer, on May 01, 2026, sold 58,424 shares in Kiniksa Pharmaceuticals International (KNSA) for $3,137,823. Following the Form 4 filing with the SEC, Paolini has control over a total of 65,623 Class A ordinary shares of the company, with 65,623 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1730430/000174153326000008/xslF345X05/form4-05052026_080527.xml

$KNSA

Insider Trading141d ago

Jazz Pharmaceuticals Insider Sold Shares Worth $1,219,980, According to a Recent SEC Filing

Bruce C Cozadd, Director, on May 01, 2026, sold 6,000 shares in Jazz Pharmaceuticals (JAZZ) for $1,219,980. Following the Form 4 filing with the SEC, Cozadd has control over a total of 378,682 ordinary shares of the company, with 378,682 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1232524/000119321026000011/xslF345X05/edgardoc.xml

$JAZZ

Insider Trading141d ago

Schneider National Insider Sold Shares Worth $426,984, According to a Recent SEC Filing

Angela M Fish, Executive Vice President, Human Resources, on May 01, 2026, sold 14,119 shares in Schneider National (SNDR) for $426,984. Following the Form 4 filing with the SEC, Fish has control over a total of 58,095 Class B common shares of the company, with 58,095 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1692063/000213104126000011/xslF345X05/primarydocument.xml

$SNDR

Insider Trading141d ago

Ebay Insider Sold Shares Worth $3,452,772, According to a Recent SEC Filing

Jordan Douglas Bradley Sweetnam, Senior Vice President, Chief Commercial Officer, on May 01, 2026, sold 33,441 shares in Ebay (EBAY) for $3,452,772. Following the Form 4 filing with the SEC, Sweetnam has control over a total of 31,137 common shares of the company, with 31,137 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1065088/000106508826000103/xslF345X05/form4.xml

$EBAY

Insider Trading141d ago

Goldman Sachs Group Insider Sold Shares Worth $3,229,543, According to a Recent SEC Filing

David M Solomon, Director, Chairman of the Board, and CEO, on May 01, 2026, sold 3,470 shares in Goldman Sachs Group (GS) for $3,229,543. Following the Form 4 filing with the SEC, Solomon has control over a total of 153,433 common shares of the company, with 137,262 shares held directly and 16,171 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/886982/000169370926000009/xslF345X05/wk-form4_1778012362.xml

$GS

Insider Trading141d ago

Willis Towers Watson Insider Bought Shares Worth $510,160, According to a Recent SEC Filing

Carl Aaron Hess, Director, Chief Executive Officer, on May 04, 2026, executed a purchase for 2,000 shares in Willis Towers Watson (WTW) for $510,160. Following the Form 4 filing with the SEC, Hess has control over a total of 117,425 ordinary shares of the company, with 117,425 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1140536/000114053626000139/xslF345X05/form4.xml

$WTW

Showing 3941-3960 of 4528